Publication: MCC950 closes the active conformation of NLRP3 to an inactive state
| dc.contributor.author | Angosto-Bazarra, Diego | |
| dc.contributor.author | Martínez-Banaclocha, Helios | |
| dc.contributor.author | Torre-Minguela, Carlos de | |
| dc.contributor.author | Cerón-Carrasco, Jose P | |
| dc.contributor.author | Pérez-Sánchez, Horacio | |
| dc.contributor.author | Arostegui, Juan I | |
| dc.contributor.author | Pelegrín Vivancos, Pablo | |
| dc.contributor.author | Tapia Abellán, Ana | |
| dc.contributor.department | Bioquímica y Biología Molecular B e Inmunología | |
| dc.date.accessioned | 2025-01-20T12:46:32Z | |
| dc.date.available | 2025-01-20T12:46:32Z | |
| dc.date.issued | 2019-06 | |
| dc.description | © 2019, The Author(s), under exclusive licence to Springer Nature America, Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Accepted Manuscript version of a Published Work that appeared in final form in Nature Chemical Biology. To access the final edited and published work see https://doi.org/10.1038/s41589-019-0278-6 | es |
| dc.description.abstract | NLRP3 is an innate immune sensor contributing to the development of different diseases including monogenic autoinflammatory syndromes, gout, atherosclerosis, and Alzheimer’s disease. The molecule sulfonylurea MCC950 is a NLRP3 inflammasome inhibitor with potential clinical utility. However, the mechanism of action of MCC950 remains unknown. Here, we characterize the mechanism of action of MCC950 in both wild-type and autoinflammatory-related NLRP3 mutants, demonstrating that MCC950 closes the ‘open’ conformation of active NLRP3. | es |
| dc.format | application/pdf | es |
| dc.format.extent | 37 | es |
| dc.identifier.citation | Nature Chemical Biology, 2019, Vol. 15, pp. 60-564 | |
| dc.identifier.doi | https://doi.org/10.1038/s41589-019-0278-6 | |
| dc.identifier.issn | Print: 1552-4450 | |
| dc.identifier.issn | Electronic: 1552-4469 | |
| dc.identifier.uri | http://hdl.handle.net/10201/148834 | |
| dc.language | eng | es |
| dc.publisher | Nature Research | |
| dc.relation | This work was supported by grants from the Instituto Salud Carlos III-Fondo Europeo de Desarrollo Regional (PI13/00174 to P.P.), the Ministerio de Economia, Industria y Competitividad–Fondo Europeo de Desarrollo Regional (project nos. SAF2017-88276-R to P.P. and CTQ2017-87974-R to H.P.-S.), Fundación Séneca (20859/PI/18 to P.P.), and the European Research Council (ERC-2013-CoG 614578 to P.P.). | es |
| dc.relation.publisherversion | https://www.nature.com/articles/s41589-019-0278-6 | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | NLRP3 | es |
| dc.subject | Inflammation | es |
| dc.subject | MCC950 | es |
| dc.subject | Mechanism of action | es |
| dc.subject | Antiinflammatory | es |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina::615 - Farmacología. Terapéutica. Toxicología. Radiología | es |
| dc.title | MCC950 closes the active conformation of NLRP3 to an inactive state | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
| relation.isAuthorOfPublication | 547c4c2c-d906-4e1d-ae9a-0cdb40eef6d1 | |
| relation.isAuthorOfPublication | 0ef289d2-ad85-4d81-a66c-82879daf26a9 | |
| relation.isAuthorOfPublication.latestForDiscovery | 547c4c2c-d906-4e1d-ae9a-0cdb40eef6d1 |
Collections
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/